Thread
The company will speed up its clinical trial recruitment measures, raise awareness of post-approval treatments and support cancer research.
The mental health company will use Curebase's decentralized clinical trial platform to study its treatment program's efficacy.
This marks THREAD's third recent acquisition, including the inVibe deal announced early this year and the Modus Outcomes purchase from November.
The acquisition is expected to help Thread customers capture real-world data.
Also: Klara closes $15 million for digital patient engagement; Trellus Health collects $5 million seed funding and announces exclusive commercialization deal.